Vor Biopharma Inc.
VOR
$23.79
-$1.32-5.24%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 21.93M | 17.57M | 16.77M | 14.42M | 12.79M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 47.85M | 35.16M | 35.96M | 29.14M | 274.28M |
| Operating Income | -47.85M | -35.16M | -35.96M | -29.14M | -274.28M |
| Income Before Tax | -62.81M | -219.59M | 1.72B | -812.68M | -1.57B |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -62.81M | -219.59M | 1.72B | -812.68M | -1.57B |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -62.81M | -219.59M | 1.72B | -812.68M | -1.57B |
| EBIT | -47.85M | -35.16M | -35.96M | -29.14M | -274.28M |
| EBITDA | -47.82M | -35.13M | -35.94M | -29.13M | -272.25M |
| EPS Basic | -1.16 | -5.11 | 84.89 | -121.63 | -251.24 |
| Normalized Basic EPS | -0.72 | -3.19 | 52.93 | -76.11 | -157.03 |
| EPS Diluted | -1.16 | -5.11 | 84.89 | -121.63 | -251.24 |
| Normalized Diluted EPS | -0.72 | -3.19 | 52.93 | -76.11 | -157.03 |
| Average Basic Shares Outstanding | 54.30M | 43.01M | 20.30M | 6.68M | 6.26M |
| Average Diluted Shares Outstanding | 54.30M | 43.01M | 20.30M | 6.68M | 6.26M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |